Natalizumab in multiple sclerosis

被引：0
|
作者：
Rajda Cecilia [1 ]
Bencsik Krisztina [1 ]
Vecsei Laszlo [1 ]
机构：
[1] Szegedi Tudomanyegyet, Szent Gyorgyi Albert Klin Kozpont, Neurol Klin, H-6725 Szeged, Hungary
来源：
IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE | 2008年 / 61卷 / 5-6期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：204 / 208
页数：5
相关论文
共 50 条
  • [21] Natalizumab for multiple sclerosis: a complicated treatment
    Keegan, B. Mark
    LANCET NEUROLOGY, 2011, 10 (08): : 677 - 678
  • [22] Natalizumab as induction therapy in multiple sclerosis
    Corlobe, A.
    Charif, M.
    Mania, A.
    Outteryck, O.
    de Seze, J.
    Labauge, P.
    REVUE NEUROLOGIQUE, 2014, 170 (01) : 2 - 5
  • [23] Is natalizumab a breakthrough in the treatment of multiple sclerosis?
    Doggrell, SA
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (06) : 999 - 1001
  • [24] Natalizumab for multiple sclerosis: the dilemma of NOVA
    Hellwig, Kerstin
    LANCET NEUROLOGY, 2022, 21 (07): : 579 - 581
  • [25] Natalizumab in the treatment of pediatric multiple sclerosis
    Talab, Radomir
    Talabova, Marika
    Klzo, Ludovit
    NEUROENDOCRINOLOGY LETTERS, 2012, 33 (06) : 579 - 589
  • [26] Natalizumab Use in Pediatric Multiple Sclerosis
    Huppke, Peter
    Stark, Wiebke
    Zuercher, Claudia
    Huppke, Brenda
    Brueck, Wolfgang
    Gaertner, Jutta
    ARCHIVES OF NEUROLOGY, 2008, 65 (12) : 1655 - 1658
  • [27] Natalizumab in multiple sclerosis: proceed with caution?
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (12) : 1675 - 1678
  • [28] Natalizumab (Tysabri) for relapsing multiple sclerosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1202): : 13 - 15
  • [29] Natalizumab in secondary progressive multiple sclerosis
    Edan, Gilles
    LANCET NEUROLOGY, 2018, 17 (05): : 384 - 385
  • [30] Multiple Sclerosis Is Natalizumab is effective as Fingolimod?
    Kilger, Ellen
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2016, 84 (05) : 256 - 256
12345